Jellagen Private

Jellagen is a medtech company that specializes in offering high-grade native collagen sourced from jellyfish. Their collagen-based innovation addresses complex tissue engineering and regenerative medical needs, making it ideal for next-generation medical treatments and scientific research. Jellagen's collagen is compatible with a broad range of cell types and is a versatile biomaterial for tissue engineering and regenerative medicine. Derived from jellyfish, their collagen avoids religious and safety concerns associated with mammalian collagen and disease transfer. With a proprietary extraction technique, Jellagen maintains the characteristic triple helix structure of collagen, making it suitable for in-vitro and in-vivo studies.

Technology: Stem Cells (Regenerative Medicine)
Headquarters: Pembroke Dock, Pembrokeshire, United Kingdom
Founded Date: 2013
Number Of Exists: Series B
Employee Number: 15
Industry: Stem Cells (Regenerative Medicine)